Humana Inc. (NYSE:HUM) Shares Bought by Empowered Funds LLC

Empowered Funds LLC increased its stake in Humana Inc. (NYSE:HUM) by 164.0% during the third quarter, HoldingsChannel.com reports. The fund owned 14,914 shares of the insurance provider’s stock after buying an additional 9,264 shares during the period. Empowered Funds LLC’s holdings in Humana were worth $4,724,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently modified their holdings of the stock. Swedbank AB raised its holdings in Humana by 3.0% during the 3rd quarter. Swedbank AB now owns 105,976 shares of the insurance provider’s stock worth $33,567,000 after buying an additional 3,085 shares during the period. Heritage Oak Wealth Advisors LLC acquired a new stake in shares of Humana during the second quarter valued at approximately $3,456,000. Mandatum Life Insurance Co Ltd raised its holdings in shares of Humana by 115.4% during the third quarter. Mandatum Life Insurance Co Ltd now owns 14,000 shares of the insurance provider’s stock valued at $4,434,000 after acquiring an additional 7,500 shares during the period. APG Asset Management US Inc. lifted its position in shares of Humana by 3.0% in the 2nd quarter. APG Asset Management US Inc. now owns 67,669 shares of the insurance provider’s stock valued at $25,274,000 after acquiring an additional 1,955 shares in the last quarter. Finally, Cetera Advisors LLC boosted its stake in Humana by 472.1% in the 1st quarter. Cetera Advisors LLC now owns 10,098 shares of the insurance provider’s stock worth $3,501,000 after purchasing an additional 8,333 shares during the period. 92.38% of the stock is owned by institutional investors and hedge funds.

Humana Trading Down 2.6 %

Shares of HUM stock opened at $275.67 on Monday. The firm has a fifty day moving average of $281.36 and a 200-day moving average of $331.94. The stock has a market cap of $33.19 billion, a price-to-earnings ratio of 24.42, a P/E/G ratio of 2.17 and a beta of 0.52. Humana Inc. has a 52-week low of $213.31 and a 52-week high of $527.18. The company has a debt-to-equity ratio of 0.67, a quick ratio of 1.76 and a current ratio of 1.76.

Humana (NYSE:HUM) last posted its quarterly earnings results on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.48 by $0.68. The firm had revenue of $29.30 billion during the quarter, compared to analyst estimates of $28.66 billion. Humana had a net margin of 1.18% and a return on equity of 13.20%. On average, equities research analysts forecast that Humana Inc. will post 15.86 earnings per share for the current fiscal year.

Humana Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Tuesday, December 31st will be paid a $0.885 dividend. This represents a $3.54 annualized dividend and a yield of 1.28%. The ex-dividend date of this dividend is Tuesday, December 31st. Humana’s dividend payout ratio is 31.36%.

Analyst Upgrades and Downgrades

Several brokerages have issued reports on HUM. KeyCorp assumed coverage on shares of Humana in a research note on Friday, October 11th. They set a “sector weight” rating on the stock. UBS Group dropped their price target on Humana from $380.00 to $250.00 and set a “neutral” rating on the stock in a research report on Friday, October 4th. Deutsche Bank Aktiengesellschaft decreased their price objective on Humana from $349.00 to $250.00 and set a “hold” rating for the company in a research report on Thursday, October 3rd. Leerink Partnrs cut Humana from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, October 2nd. Finally, Jefferies Financial Group lowered shares of Humana from a “buy” rating to a “hold” rating and reduced their price target for the stock from $519.00 to $253.00 in a research report on Monday, October 7th. Twenty research analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $315.86.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.